Eledon Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Eledon Pharmaceuticals

24/03/2022 21:02

* Eledon Pharmaceuticals Inc  ELDN.OQ  reported a quarterly
adjusted loss of 59 cents​​ per share for the quarter ended in
December. The mean expectation of five analysts for the quarter
was for a loss of 75 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Eledon Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 59 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Eledon Pharmaceuticals Inc shares had fallen by 14.1% this
quarter.
    * The company reported a quarterly loss of $8.81 million.
    * Wall Street's median 12-month price target for Eledon
Pharmaceuticals Inc is $25.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 24 at 09:01 p.m.  ​All
figures in US dollars unless otherwise stated